Ekso Bionics director Stern resigns; CEO bonus potential raised to 75% of salary

EKSO BIONICS HOLDINGS, INC.

Stanley Stern resigns from board effective April 26, 2023; no disagreement with Company.
Stern's unvested RSUs under 2014 Equity Incentive Plan to fully vest on resignation.
CEO Scott Davis's 2023 bonus potential increased from 50% to 75% of base salary.
Board restated articles to remove Series A Preferred certificate of designations (no shares outstanding).
Bylaws amended to address universal proxy rules and update meeting procedures.

item 5.02 item 5.03 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Stanley Stern

director

CHRN · EKSO BIONICS HOLDINGS, INC.

Effective: 2023-04-26
Filed: April 26, 2023, 7:59 PM ET

On April 25, 2023, Stanley Stern, a member of the board of directors (the “Board”) of Ekso Bionics Holdings, Inc. (the “Company”), notified the Company of his resignation from the Board, effective on April 26, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stanley Stern resigned as director at EKSO BIONICS HOLDINGS, INC..

Action: resigned
Role: director

Exact text from the filing

On April 25, 2023, Stanley Stern, a member of the board of directors (the “Board”) of Ekso Bionics Holdings, Inc. (the “Company”), notified the Company of his resignation from the Board, effective on April 26, 2023.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

EKSO BIONICS HOLDINGS, INC.: Amended and restated bylaws to address universal proxy rules and update provisions related to calling of stockholder and Board meetings (effective 2023-04-20).

Change: bylaw amendment
Effective: 2023-04-20

Exact text from the filing

On April 20, 2023, the Board of the Company adopted amended and restated bylaws (the “Amended and Restated Bylaws”), which became effective immediately. Among other things, the Amended and Restated Bylaws address the universal proxy rules adopted by the U.S. Securities and Exchange Commission and update certain provisions related to the calling of stockholder and Board meetings.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

EKSO BIONICS HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001549084-23-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.